The $590 billion Medicaid program is exceptionally complex. Medicaid’s massive size, astonishing complexity, varied roles, rapidity of change, and slim administrative resources all combine to make it …
Today, prices driving prescription drug spending are largely rooted in a long history of pricing by dosing unit. In most cases, the pricing of a …
Health care payment reform efforts focus on substituting cost-effective value for volume and ultimately aligning the financial incentives of provider reimbursement with expectations for patient outcomes, …
The massive reforms to Medicare physician reimbursement mandated under Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) present many issues and opportunities for accountable care organizations …
Global drug pricing continues to ignite fresh controversies as health policy makers, government health programs, health insurers, and pharmaceutical companies meet in heated debate. Solutions for …
How have alternative health care payment models, aimed at lowering costs while improving patient outcomes, affected physicians and physician practices in the United States? A …
The Affordable Care Act (ACA) is changing the health care landscape for everyone, including safety net hospitals. Just how this change will affect these key …
Hospital readmissions are costly but largely preventable. Reducing inpatient readmissions are a top priority for Medicare, state Medicaid programs, and private health plans. The opportunities …
To control rising health care costs and improve outcomes, health care purchasers – Medicare, state Medicaid programs, and large employers – and health plans are …
States across the US are engaged in ambitious and critically important initiatives to reform health care payment and care delivery. Partnering with other major health …
